Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Submitted by
admin
on January 3, 2012 - 11:31am
Source:
Bloomberg
News Tags:
Aveo Pharmaceutical
Astellas
renal cell carcinoma
tivozanib
Headline:
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Do Not Allow Advertisers to Use My Personal information
